UBS Maintains Neutral on Clorox, Lowers Price Target to $110

Benzinga Newsdesk www.benzinga.com Negative 79.5%

Neg 79.5% Neu 0% Pos 0%

UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $121 to $110.

Comments

No comments yet. Be the first!